Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Rodman David Malcom
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
69%
Avg. Sale Return
30%
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
15%
11%
49%
44%
69%
Sale Success Rate
1 of 3
1 of 3
2 of 3
2 of 3
3 of 3
Nivalis Therapeutics, Inc.
Drugs
» Biotechnology
Exec Vice President and CMO:
Holdings:
11.37K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Mineralys Therapeutics, Inc.
Other
» Other
Chief Medical Officer:
Holdings:
135.97K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--